Maria-Christina Jung
FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C
Heeg M, Spannagl M, Kauke T, Horster S, Schraut W, Raziorrouh B, Gerlach T, Jung M, Zachoval R, Grüner N, Ulsenheimer A, Diepolder H. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C. Gastroenterology 2009; 137:1280-8.e1-6.
01.10.2009FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C
01.10.2009Gastroenterology 2009; 137:1280-8.e1-6
Heeg Malte H J, Spannagl Michael, Kauke Teresa, Horster Sophia, Schraut Winfried, Raziorrouh Bijan, Gerlach Tilman, Jung Maria-Christina, Zachoval Reinhart, Grüner Norbert H, Ulsenheimer Axel, Diepolder Helmut M
Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine
Gruener N, Gerlach T, Ulsenheimer A, Diepolder H, Wierenga E, Zachoval R, Heeg M, Pape G, Jung M. Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine. Vaccine 2007; 25:4960-6.
21.06.2007Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine
21.06.2007Vaccine 2007; 25:4960-6
Gruener Norbert H, Gerlach Tilman, Ulsenheimer Axel, Diepolder Helmut M, Wierenga Eddy, Zachoval Reinhart, Heeg Malte, Pape Gerd Rudolf, Jung Maria-Christina
Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection
Lucas M, Santantonio T, Fidler S, Thimme R, Haberstroh A, Baumert T, Klenerman P, Diepolder H, Nitschko H, Obermeier M, Phillips R, Scriba T, Semmo N, Day C, Weber J, Schraut W, Pape G, Zachoval R, Ulsenheimer A, Pfafferot K, Heeg M, Gaudieri S, Grüner N, Rauch A, Gerlach T, Jung M. Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection. PloS one 2007; 2:e649.
01.01.2007Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection
01.01.2007PloS one 2007; 2:e649
Lucas Michaela, Santantonio Teresa, Fidler Sarah, Thimme Robert, Haberstroh Anita, Baumert Thomas F, Klenerman Paul, Diepolder Helmut M, Nitschko Hans, Obermeier Martin, Phillips Rodney, Scriba Thomas J, Semmo Nasser, Day Cheryl, Weber Jonathan N, Schraut Winfried, Pape Gerd R, Zachoval Reinhart, Ulsenheimer Axel, Pfafferot Katja, Heeg Malte H J, Gaudieri Silvana, Grüner Norbert, Rauch Andri, Gerlach Tilman, Jung Maria-Christina
Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection
Ulsenheimer A, Pape G, Zachoval R, Schirren C, Heeg M, Schraut W, Santantonio T, Backmund M, Wächtler M, Gruener N, Jung M, Gerlach T, Diepolder H. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology (Baltimore, Md.) 2005; 41:643-51.
01.03.2005Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection
01.03.2005Hepatology (Baltimore, Md.) 2005; 41:643-51
Ulsenheimer Axel, Pape Gerd R, Zachoval Reinhart, Schirren Carl A, Heeg Malte H J, Schraut Winfried, Santantonio Teresa, Backmund Markus, Wächtler Martin, Gruener Norbert, Jung Maria-Christina, Gerlach Tilman, Diepolder Helmut M
Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation
Gruener N, Pape G, Schauer R, Baretton G, Diepolder H, Zachoval R, Gerlach T, Ulsenheimer A, Jung M, Schirren C. Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004; 10:1487-96.
01.12.2004Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation
01.12.2004Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004; 10:1487-96
Gruener Norbert Hubert, Pape Gerd Rudolf, Schauer Rolf, Baretton Gustavo, Diepolder Helmut Michael, Zachoval Reinhart, Gerlach Tilman, Ulsenheimer Axel, Jung Maria-Christina, Schirren Carl Albrecht
Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination
Schirren C, Pape G, Nitschko H, Rau H, Schraut W, Baretton G, Diepolder H, Gruener N, Ulsenheimer A, Gerlach T, Zachoval R, Jung M. Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination. Journal of hepatology 2003; 39:397-404.
01.09.2003Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination
01.09.2003Journal of hepatology 2003; 39:397-404
Schirren Carl Albrecht, Pape Gerd Rudolf, Nitschko Hans, Rau Horst-Guenter, Schraut Winfried, Baretton Gustavo, Diepolder Helmut Michael, Gruener Norbert Hubert, Ulsenheimer Axel, Gerlach Tilman, Zachoval Reinhart, Jung Maria-Christina
Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance
Gerlach T, Backmund M, Waechtler M, Schirren C, Schraut W, Ulsenheimer A, Jung M, Gruener N, Zachoval R, Diepolder H, Pape G. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003; 125:80-8.
01.07.2003Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance
01.07.2003Gastroenterology 2003; 125:80-8
Gerlach Tilman, Backmund M, Waechtler M, Schirren C Albrecht, Schraut Winfried W, Ulsenheimer Axel, Jung Maria-Christina, Gruener Norbert H, Zachoval Reinhart, Diepolder Helmut M, Pape Gerd R
Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C
Ulsenheimer A, Gerlach T, Gruener N, Jung M, Schirren C, Schraut W, Zachoval R, Pape G, Diepolder H. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology (Baltimore, Md.) 2003; 37:1189-98.
01.05.2003Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C
01.05.2003Hepatology (Baltimore, Md.) 2003; 37:1189-98
Ulsenheimer Axel, Gerlach Tilman, Gruener Norbert H, Jung Maria-Christina, Schirren Carl-Albrecht, Schraut Winfried, Zachoval Reinhart, Pape Gerd R, Diepolder Helmut M
Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response
Gruener N, Backmund M, Wächtler M, Hoffmann R, Schirren C, Diepolder H, Gerlach T, Ulsenheimer A, Jung M, Pape G. Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response. Journal of hepatology 2002; 37:866-9.
01.12.2002Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response
01.12.2002Journal of hepatology 2002; 37:866-9
Gruener Norbert H, Backmund Markus, Wächtler Martin, Hoffmann Robert, Schirren Carl A, Diepolder Helmut M, Gerlach Tilman, Ulsenheimer Axel, Jung Maria-Christina, Pape Gerd R
Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers
Jung M, Zeuzem S, Trojan J, Whitehead E, Birtles E, Bailey J, Page M, Schirren C, Diepolder H, Gerlach T, Schraut W, Zachoval R, Grüner N, Pape G. Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers. Vaccine 2002; 20:3598-612.
04.10.2002Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers
04.10.2002Vaccine 2002; 20:3598-612
Jung Maria-Christina, Zeuzem Stefan, Trojan Jörg, Whitehead Eve, Birtles Emma, Bailey John, Page Mark, Schirren Carl-Albrecht, Diepolder Helmut, Gerlach Tilman, Schraut Winfried, Zachoval Reinhart, Grüner Norbert, Pape Gerd R